Mark G Lebwohl, MD Email Mark Lebwohl
- DEAN FOR CLINICAL THERAPEUTICS
- PROFESSOR | Dermatology
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Queens
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Doctors East 98th Street 212-241-9728 212-241-9728
Book an Appointment - Mark G Lebwohl, MD
Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai.
Dr. Lebwohl has been practicing dermatology since 1983. He is the Dean of Clinical Therapeutics at the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. Dr. Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl is a past chairman of the Psoriasis Task Force of the American Academy of Dermatology, and has directed the AAD's annual Psoriasis Symposium, Diagnostic Update Symposium and Therapeutics Symposium. In 2015-16 he served as President of the American Academy of Dermatology.
Dr. Lebwohl is chairman emeritus of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He has been on the editorial board of the Journal of the American Academy of Dermatology and the Journal of Skin Cancer. He is editor of the Dermatology Section of Scientific American Medicine and co-Editor-in-Chief of Skin, the Journal of Cutaneous Medicine. Dr. Lebwohl has chaired numerous symposia and has written or edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease, now in its fifth edition. His books have been translated into numerous foreign languages, including French, Portuguese, Chinese and Polish. Other books include Difficult Diagnoses in Dermatology and Psoriasis. He has authored or co-authored over 500 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.In The News
Dr. Lebwohl discusses skin cancer in The Daily News.
American Board of Dermatology
American Board of Internal Medicine
MD, Harvard Medical School
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai Hospital
English, Spanish, Hebrew
America's Top Doctors
New York Magazine
President's Volunteer Service Award
American Academy of Dermatology Bronze Award
Leadership Circle for Volunteerism
American Academy of Dermatology
Best Teacher & Mentor of the Millenium
Dermatology Residents, Mount Sinai
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lebwohl during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Aditum Bio
- Allergan, Inc.
- Anaptys Bio
- Arcutis, Inc.
- Aristea Therapeutics
- Avotres Therapeutics
- BMD Skincare, Inc.
- BirchBioMed, Inc.
- Boehringer Ingelheim Corporation
- Bristol-Myers Squibb
- Cara Therapeutics
- Castle Biosciences
- Dermavant Sciences
- Dr. Reddy Laboratories
- EMD Serono, Inc. (Merck & Co., Inc.)
- Evelo Biosciences
- Evommune Inc.
- Forte Biosciences
- Helsinn Therapeutics
- Inozyme Pharma
- LEO Pharma Inc.
- Meiji Seika Pharma
- Menlo Therapeutics
- Mitsubishi Tanabe Pharma
- National Psoriasis Foundation
- Neuroderm ltd.
- Pfizer Inc.
- Promius Pharma, LLC.
- Verrica Pharmaceuticals
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Facilitation of International Dermatology Education (FIDE)
- New York College of Podiatric Medicine (NYCPM)
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- American Academy of Dermatology
- Foundation for Research and Education in Dermatology
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.